TÀI LIỆU THAM KHẢO (tiếp theo)
40. Akter, M., Araf, Y., Akter, S. & Hossain, M. G. Dengue in Bangladesh: a gendered perspective on infection and fatality rates amidst global epidemiological trends. J. Arthropod‐Borne Dis. 18, 281‐284 https://doi.org/10.18502/jad.v18i3.18579 (2024).
41. Mulligan, K., Dixon, J., Sinn, C.‐L. J. & Elliott, S. J. Is dengue a disease of poverty? A systematic review. Pathog. Glob. Health 109, 10‐18
42. Abd‐Jamil, J. et al. Possible factors influencing the seroprevalence of dengue among residents of the forest fringe areas of Peninsular Malaysia. J. Trop. Med. 2020, 1019238
43. Aye, K. S. et al. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum. Pathol. 45, 1221‐1233 https://doi.org/10.1016/j.humpath.2014.01.022 (2014).
44. Mittler, E. et al. LRP8 is a receptor for tick‐borne encephalitis virus. Nature 646, 945‐952 https://doi.org/10.1038/s41586‐025‐09500‐2 (2025).
45. Li, P. et al. LRP8 is an entry receptor for tick‐borne encephalitis viruses. Proc. Natl Acad. Sci. USA 122, e2525771122 https://doi.org/10.1073/pnas.2525771122 (2025).
46. Chong, Z. et al. Multiple LDLR family members act as entry receptors for yellow fever virus. Nature 649, 173‐182 https://doi.org/10.1038/s41586‐025‐09689‐2 (2026).
47. Mei, M. et al. LRP8 is a functional receptor for yellow fever virus. Nat. Microbiol. 11, 1022‐1036 https://doi.org/10.1038/s41564‐026‐02278‐7 (2026).
48. Cruz‐Oliveira, C. et al. Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol. Rev. 39, 155‐170 https://doi.org/10.1093/femsre/fuu004 (2015).
49. Chen, Y. et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3, 866‐871 https://doi.org/10.1038/nm0897‐866 (1997).
50. Tassaneetrithep, B. et al. DC‐SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823‐829 https://doi.org/10.1084/jem.20021840 (2003).
51. Navarro‐Sanchez, E. et al. Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses. EMBO Rep. 4, 723‐728 https://doi.org/10.1038/sj.embor.embor866 (2003).
52. Jindadamrongwech, S., Thepparit, C. & Smith, D. R. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 149, 915‐927 https://doi.org/10.1007/s00705‐003‐0263‐x (2004).
53. Reyes‐del Valle, J., Chávez‐Salinas, S., Medina, F. & del Angel, R. M. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 79, 4557‐4567 https://doi.org/10.1128/JVI.79.8.4557‐4567.2005 (2005).
54. Meertens, L. et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12, 544‐557 https://doi.org/10.1016/j.chom.2012.08.009 (2012).
55. Ooi, E. E. & Kalimuddin, S. Insights into dengue immunity from vaccine trials. Sci. Transl. Med. 15, eadh3067 https://doi.org/10.1126/scitranslmed.adh3067 (2023).
56. Gebo, C. et al. B cell receptor dependent enhancement of dengue virus infection. PLoS Pathog. 20, e1012683 https://doi.org/10.1371/journal.ppat.1012683 (2024).
57. Zanini, F. et al. Virus‐inclusive single‐cell RNA sequencing reveals the molecular signature of progression to severe dengue. Proc. Natl Acad. Sci. USA 115, E12363‐E12369 https://doi.org/10.1073/pnas.1813819115 (2018).
58. Mercer, J., Schelhaas, M. & Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem. 79, 803‐833 https://doi.org/10.1146/annurev‐biochem‐060208‐104626 (2010).
59. Hackett, B. A. et al. RNASEK is required for internalization of diverse acid‐dependent viruses. Proc. Natl Acad. Sci. USA 112, 7797‐7802. https://doi.org/10.1073/pnas.1424098112 (2015).
60. Perreira, J. M. et al. RNASEK is a V‐ATPase‐associated factor required for endocytosis and the replication of rhinovirus, influenza A virus, and dengue virus. Cell Rep. 12, 850‐863 https://doi.org/10.1016/j.celrep.2015.06.076 (2015).
61. Hackett, B. A. & Cherry, S. Flavivirus internalization is regulated by a size‐dependent endocytic pathway. Proc. Natl Acad. Sci. USA 115, 4246‐4251 https://doi.org/10.1073/pnas.1720032115 (2018).
62. Pierson, T. C. & Kielian, M. Flaviviruses: braking the entering. Curr. Opin. Virol. 3, 3‐12 https://doi.org/10.1016/j.coviro.2012.12.001 (2013).
63. Barrows, N. J. et al. Dual roles for the ER membrane protein complex in flavivirus infection: viral entry and protein biogenesis. Sci. Rep. 9, 9711 https://doi.org/10.1038/s41598‐019‐45910‐9 (2019).
64. Bagchi, P., Speckhart, K., Kennedy, A., Tai, A. W. & Tsai, B. A specific EMC subunit supports dengue virus infection by promoting virus membrane fusion essential for cytosolic genome delivery. PLoS Pathog. 18, e1010717 https://doi.org/10.1371/journal.ppat.1010717 (2022).
65. Byk, L. A. et al. Dengue virus genome uncoating requires ubiquitination. mBio 7, e00804‐16 https://doi.org/10.1128/mBio.00804‐16 (2016).
66. Ooi, Y. S. et al. An RNA‐centric dissection of host complexes controlling flavivirus infection. Nat. Microbiol. 4, 2369‐2382 https://doi.org/10.1038/s41564‐019‐0518‐2 (2019).
67. Edgil, D., Polacek, C. & Harris, E. Dengue virus utilizes a novel strategy for translation initiation when cap‐dependent translation is inhibited. J. Virol. 80, 2976‐2986 https://doi.org/10.1128/JVI.80.6.2976‐2986.2006 (2006).
68. Reid, D. W. et al. Dengue virus selectively annexes endoplasmic reticulum‐associated translation machinery as a strategy for co‐opting host cell protein synthesis. J. Virol. 92, e01766‐17 https://doi.org/10.1128/JVI.01766‐17 (2018).
69. Verhaegen, M. et al. Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan‐orthoflavivirus antiviral potency. Cell Rep. 44, 116642 https://doi.org/10.1016/j.celrep.2025.116642 (2025).
70. Marceau, C. D. et al. Genetic dissection of Flaviviridae host factors through genome‐scale CRISPR screens. Nature 535, 159‐163 https://doi.org/10.1038/nature18631 (2016).
71. Zhang, R. et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature 535, 164‐168 https://doi.org/10.1038/nature18625 (2016).
72. Ngo, A. M. et al. The ER membrane protein complex is required to ensure correct topology and stable expression of flavivirus polyproteins. eLife 8, e48469 https://doi.org/10.7554/eLife.48469 (2019).
73. Schmidt, H. M. & Horner, S. M. Towards a universal translator: decoding the PTMs that regulate orthoflavivirus infection. Viruses 17, 287 https://doi.org/10.3390/v17020287 (2025).
74. Brugier, A. et al. RACK1 associates with RNA‐binding proteins vigilin and SERBP1 to facilitate dengue virus replication. J. Virol. 96, e01962‐21 https://doi.org/10.1128/jvi.01962‐21 (2022).
75. Shue, B. et al. Genome‐wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication. J. Virol. 95, e00596‐21 https://doi.org/10.1128/JVI.00596‐21 (2021).
76. Umareddy, I. et al. Dengue virus serotype infection specifies the activation of the unfolded protein response. Virol. J. 4, 91 https://doi.org/10.1186/1743‐422X‐4‐91 (2007).
77. Klomporn, P., Panyasrivanit, M., Wikan, N. & Smith, D. R. Dengue infection of monocytic cells activates ER stress pathways, but apoptosis is induced through both extrinsic and intrinsic pathways. Virology 409, 189‐197 https://doi.org/10.1016/j.virol.2010.10.010(2011).
78. Peña, J. & Harris, E. Dengue virus modulates the unfolded protein response in a time‐dependent manner. J. Biol. Chem. 286, 14226‐14236 https://doi.org/10.1074/jbc.M111.222703 (2011).
79. Tabata, K. et al. Endoplasmic reticulum‐associated degradation controls virus protein homeostasis, which is required for flavivirus propagation. J. Virol. 95, e0223420 https://doi.org/10.1128/JVI.02234‐20 (2021).
80. Taguwa, S. et al. Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in flavivirus infection. Cell 163, 1108‐1123 https://doi.org/10.1016/j.cell.2015.10.046 (2015).
81. Neufeldt, C. J. et al. ER‐shaping atlastin proteins act as central hubs to promote flavivirus replication and virion assembly. Nat. Microbiol. 4, 2416‐2429 https://doi.org/10.1038/s41564‐019‐0586‐3 (2019).
82. Mazeaud, C. et al. The biogenesis of dengue virus replication organelles requires the ATPase activity of valosin‐containing protein. Viruses 13, 2092 https://doi.org/10.3390/v13102092 (2021).
83. Aktepe, T. E., Liebscher, S., Prier, J. E., Simmons, C. P. & Mackenzie, J. M. The host protein reticulon 3.1A is utilized by flaviviruses to facilitate membrane remodelling. Cell Rep. 21, 1639‐1654 https://doi.org/10.1016/j.celrep.2017.10.055 (2017).
84. Hoffmann, H.‐H. et al. TMEM41B is a pan‐flavivirus host factor. Cell 184, 133‐148.e20 https://doi.org/10.1016/j.cell.2020.12.005 (2021).
85. Yousefi, M. et al. TMEM41B and VMP1 modulate cellular lipid and energy metabolism for facilitating dengue virus infection. PLoS Pathog. 18, e1010763 https://doi.org/10.1371/journal.ppat.1010763 (2022).
86. Chatel‐Chaix, L. & Bartenschlager, R. Dengue virus‐ and hepatitis C virus‐induced replication and assembly compartments: the enemy inside‐caught in the web. J. Virol. 88, 5907‐5911 https://doi.org/10.1128/JVI.03404‐13 (2014).
87. Heaton, N. S. & Randall, G. Dengue virus‐induced autophagy regulates lipid metabolism. Cell Host Microbe 8, 422‐432 https://doi.org/10.1016/j.chom.2010.10.006 (2010).
88. Pierson, T. C. & Diamond, M. S. Degrees of maturity: the complex structure and biology of flaviviruses. Curr. Opin. Virol. 2, 168‐175 https://doi.org/10.1016/j.coviro.2012.02.011 (2012).
89. Malavige, G. N. & Ogg, G. S. Molecular mechanisms in the pathogenesis of dengue infections. Trends Mol. Med. 30, 484‐498 https://doi.org/10.1016/j.molmed.2024.03.006 (2024).
90. Moallemi, S., Lloyd, A. R. & Rodrigo, C. Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta‐analysis. Sci. Rep. 13, 17485 https://doi.org/10.1038/s41598‐023‐44559‐9 (2023).
91. Ghita, L. et al. Global and cell type‐specific immunological hallmarks of severe dengue progression identified via a systems immunology approach. Nat. Immunol. 24, 2150‐2163 https://doi.org/10.1038/s41590‐023‐01654‐3 (2023).
92. Tissera, H. et al. Chymase level is a predictive biomarker of dengue hemorrhagic fever in pediatric and adult patients. J. Infect. Dis. 216, 1112‐1121 https://doi.org/10.1093/infdis/jix447 (2017).
93. Rathore, A. P. S. et al. Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients. Sci. Rep. 10, 11856 https://doi.org/10.1038/s41598‐020‐68844‐z (2020).
94. Loke, W. M. et al. Augmentation of 5‐lipoxygenase activity and expression during dengue serotype‐2 infection. Virol. J. 10, 322 https://doi.org/10.1186/1743‐422X‐10‐322 (2013).
95. Chia, P. Y., Teo, A. & Yeo, T. W. Association of neutrophil mediators with dengue disease severity and cardiac impairment in adults. J. Infect. Dis. 226, 1974‐1984 https://doi.org/10.1093/infdis/jiac383 (2022).
96. Chua, C. L. L., Morales, R. F., Chia, P. Y., Yeo, T. W. & Teo, A. Neutrophils — an understudied bystander in dengue? Trends Microbiol. 32, 1132‐1142 https://doi.org/10.1016/j.tim.2024.04.011 (2024).
97. Singh, A. et al. Early neutrophil responses are potential biomarkers to predict severe COVID‐19 in adults. J. Leukoc. Biol. https://doi.org/10.1093/jleuko/qiaf035 (2025).
98. Yacoub, S., Wertheim, H., Simmons, C. P., Screaton, G. & Wills, B. Microvascular and endothelial function for risk prediction in dengue: an observational study. Lancet 385, S102 https://doi.org/10.1016/S0140‐6736(15)60417‐2 (2015).
99. Yacoub, S. et al. Association of microvascular function and endothelial biomarkers with clinical outcome in dengue: an observational study. J. Infect. Dis. 214, 697‐706 https://doi.org/10.1093/infdis/jiw220 (2016).
100. Yacoub, S. et al. Endothelial nitric oxide pathways in the pathophysiology of dengue: a prospective observational study. Clin. Infect. Dis. 65, 1453‐1461 https://doi.org/10.1093/cid/cix567 (2017).
101. Vuong, N. L. et al. Dengue viremia kinetics and effects on platelet count and clinical outcomes: an analysis of 2340 patients from Vietnam. eLife 13, RP92606 https://doi.org/10.7554/eLife.92606 (2024).
102. Chan, C. Y. Y. et al. Antibody‐dependent dengue virus entry modulates cell intrinsic responses for enhanced infection. mSphere 4, e00528‐19 https://doi.org/10.1128/msphere.00528‐19 (2019).
103. Yuya, W. et al. Progress and challenges in development of animal models for dengue virus infection. Emerg. Microbes Infect. 13, 2404159
104. Lyke, K. E. et al. Efficacy and immunogenicity following dengue virus‐1 human challenge after a tetravalent prime‐boost dengue vaccine regimen: an open‐label, phase 1 trial. Lancet Infect. Dis. 24, 896‐1121 https://doi.org/10.1016/S1473‐3099(24)00100‐2 (2024).
105. Snow, G. E., Haaland, B., Ooi, E. E. & Gubler, D. J. Review article: research on dengue during World War II revisited. Am. J. Trop. Med. Hyg. 91, 1203‐1217
106. Vaughn, D. W. et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181, 2‐1121
107. Tricou, V., Minh, N. N., Farrar, J., Tran, H. T. & Simmons, C. P. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl. Trop. Dis. 5, e1121 https://doi.org/10.1371/journal.pntd.0001309 (2011).
108. Hardy, C. S. C., Wegman, A. D., Waldran, M. J., Chan, G. C. & Waickman, A. T. Conventional and antibody‐enhanced DENV infection of human macrophages induces differential immunotranscriptomic profiles. J. Virol. 99, e1121
109. Wang, T. T. et al. IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity. Science 355, 395‐398 https://doi.org/10.1126/science.aai8128 (2017).
110. Bournazos, S. et al. Antibody fucosylation predicts disease severity in secondary dengue infection. Science 372, 1102‐1105 https://doi.org/10.1126/science.abc7303 (2021).
111. Cardona‐Ospina, J. A. et al. IgA‐driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans. Nat. Immunol. 27, 126‐134 https://doi.org/10.1038/s41590‐025‐02363‐9 (2026).
112. Aggarwal, C. et al. Severe disease during both primary and secondary dengue virus infections in pediatric populations. Nat. Med. 30, 670‐674 https://doi.org/10.1038/s41591‐024‐02798‐x (2024).
113. Vuong, N. L. et al. Higher plasma viremia in the febrile phase is associated with adverse dengue outcomes irrespective of infecting serotype or host immune status: an analysis of 5642 Vietnamese cases. Clin. Infect. Dis. 72, e1074‐e1083 https://doi.org/10.1093/cid/ciaa1840 (2021).
114. Biswal, S. et al. Efficacy of a tetravalent dengue vaccine in healthy children aged 4‐16 years: a randomised, placebo‐controlled, phase 3 trial. Lancet 395, 1423‐1433 https://doi.org/10.1016/S0140‐6736(20)30414‐1 (2020).
115. Nogueira, M. L. et al. Efficacy and safety of Butantan‐DV in participants aged 2‐59 years through an extended follow‐up: results from a double‐blind, randomised, placebo‐controlled, phase 3, multicentre trial in Brazil. Lancet Infect. Dis. 24, 1234‐1244 https://doi.org/10.1016/S1473‐3099(24)00376‐1 (2024).
116. Ong, E. Z. et al. Dengue virus infection reprograms baseline innate immune gene expression. Med 6, 100841 https://doi.org/10.1016/j.medj.2025.100841 (2025).
117. Aguirre, S. et al. Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. Nat. Microbiol. 2, 1121 https://doi.org/10.1038/nmicrobiol.2017.37 (2017).
118. Ashour, J., Laurent‐Rolle, M., Shi, P.‐Y. & García‐Sastre, A. NS5 of dengue virus mediates STAT2 binding and degradation. J. Virol. 83, 5408‐5418 https://doi.org/10.1128/JVI.02188‐08 (2009).
119. Muñoz‐Jordán, J. L. et al. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79, 8004‐8013 https://doi.org/10.1128/JVI.79.13.8004‐8013.2005 (2005).
120. Muñoz‐Jordan, J. L., Sánchez‐Burgos, G. G., Laurent‐Rolle, M. & García‐Sastre, A. Inhibition of interferon signaling by dengue virus. Proc. Natl Acad. Sci. USA 100, 14333‐14338 https://doi.org/10.1073/pnas.2335168100 (2003).
121. Manokaran, G. et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 350, 217‐221 https://doi.org/10.1126/science.aab3369 (2015).
122. Syenina, A. et al. Positive epistasis between viral polymerase and the 3′ untranslated region of its genome reveals the epidemiologic fitness of dengue virus. Proc. Natl Acad. Sci. USA 117, 11038‐11047 https://doi.org/10.1073/pnas.1919287117 (2020).
123. Shah, P. S. et al. Comparative flavivirus‐host protein interaction mapping reveals mechanisms of dengue and Zika virus pathogenesis. Cell 175, 1931‐1945.e18 https://doi.org/10.1016/j.cell.2018.11.028 (2018).
124. Liao, K.‐C. et al. Dengue and Zika RNA‐RNA interactomes reveal pro‐ and anti‐viral RNA in human cells. Genome Biol. 24, 279 https://doi.org/10.1186/s13059‐023‐03110‐9 (2023).
125. Gonnella, G. et al. Immune profiling in subclinical secondary dengue‐infected cases reveals adaptive immune signatures correlated to protection from severe dengue. Cell Host Microbe 33, 1191‐1207.e4 https://doi.org/10.1016/j.chom.2025.06.006 (2025).
126. Sungnak, W. et al. Distinct systemic immune responses in asymptomatic and symptomatic dengue virus infection. Sci. Transl. Med. 17, eads5932 https://doi.org/10.1126/scitranslmed.ads5932 (2025).
127. Loke, H. et al. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am. J. Trop. Med. Hyg. 67, 102‐106 https://doi.org/10.4269/ajtmh.2002.67.102 (2002).
128. García, G. et al. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcγRIIa polymorphism. Am. J. Trop. Med. Hyg. 82, 1153‐1156 https://doi.org/10.4269/ajtmh.2010.09‐0353 (2010).
129. Cansanção, I. F., do Carmo, A. P. S., Leite, R. D. & Rabenhorst, S. H. B. Association of polymorphisms in IL1β‐511C>T, IL1RN 86 bp VNTR, and IL6 ‐174G>C genes with clinical dengue signs and symptoms in Brazilian dengue patients. Viral Immunol. 29, 372‐376 https://doi.org/10.1089/vim.2015.0082 (2016).
130. Cansanção, I. F. et al. Association of genetic polymorphisms of IL1β ‐511 C>T, IL1RN VNTR 86 bp, IL6 ‐174 G>C, IL10 ‐819 C>T and TNFα ‐308 G>A, involved in symptomatic patients with dengue in Brazil. Inflamm. Res. 65, 925‐932 https://doi.org/10.1007/s00011‐016‐0975‐5 (2016).
131. Sierra, B. et al. HLA‐A, ‐B, ‐C, and ‐DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum. Immunol. 68, 531‐540 https://doi.org/10.1016/j.humimm.2007.03.001 (2007).
132. Vejbaesya, S. et al. TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J. Infect. Dis. 199, 1442‐1448 https://doi.org/10.1086/597422 (2009).
133. Khor, C. C. et al. Genome‐wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat. Genet. 43, 1139‐1141 https://doi.org/10.1038/ng.960 (2011).
134. Gregorova, M. et al. Early NK‐cell and T‐cell dysfunction marks progression to severe dengue in patients with obesity and healthy weight. Nat. Commun. 16, 5569 https://doi.org/10.1038/s41467‐025‐60941‐9 (2025).
135. Tay, C. J. X. et al. Over‐induction of innate immune responses suppresses T cell response to mRNA SARS‐CoV‐2 vaccination. Vaccine 88, 128983 https://doi.org/10.1016/j.vaccine.2026.128983 (2026).
136. Wilder‐Smith, A., Ooi, E. E., Horstick, O. & Wills, B. Dengue. Lancet 393, 350‐363 https://doi.org/10.1016/S0140‐6736(18)32560‐1 (2019).
137. Sangkaew, S. et al. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta‐analysis. Lancet Infect. Dis. 21, 1014‐1026 https://doi.org/10.1016/S1473‐3099(20)30601‐0 (2021).
138. Michels, M. et al. The predictive diagnostic value of serial daily bedside ultrasonography for severe dengue in Indonesian adults. PLoS Negl. Trop. Dis. 7, e2277 https://doi.org/10.1371/journal.pntd.0002277 (2013).
139. Campana, V. et al. Liver involvement in dengue: a systematic review. Rev. Med. Virol. 34, e2564 https://doi.org/10.1002/rmv.2564 (2024).
140. Yacoub, S., Wertheim, H., Simmons, C. P., Screaton, G. & Wills, B. Cardiovascular manifestations of the emerging dengue pandemic. Nat. Rev. Cardiol. 11, 335‐345 https://doi.org/10.1038/nrcardio.2014.40 (2014).
(Hết Phần 8) —‐> (Tiếp theo Phần 9)
TS.BS. Huỳnh Hồng Quang & TS. Nguyễn Thị Liên Hạnh
Viện Sốt rét‐KST‐CT Quy Nhơn











